Physician profile
David Wicker
NPI 1306476957
$6,623.06
in general payments reported to CMS, 2019-2025
29 companies · $3,517 in 2025
The $3,517 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.35 · 2022: $43.35 · 2023: $738 · 2024: $2,275 · 2025: $3,517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,346 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,345.62 |
| Education | $184.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,000.22 | 2023-2025 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $767.20 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $473.02 | 2023-2025 | Ofev, Stiolto Respimat, Jascayd |
| Genzyme Corporation | $469.16 | 2023-2025 | |
| Electromed, INC. | $447.64 | 2024-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $370.88 | 2024-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $335.73 | 2023-2025 | Acthar |
| Insmed, INC. | $312.63 | 2023-2025 | Arikayce, Brinsupri |
| Harmony Biosciences LLC | $286.88 | 2024-2025 | |
| Baxter Healthcare | $276.97 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| United Therapeutics Corporation | $255.24 | 2024-2025 | Tyvaso, Tyvaso |
| Vifor Pharma, INC. | $212.60 | 2024-2025 | Zemaira, Veltassa |
| Sanofi-Aventis U.S. LLC | $184.74 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $167.73 | 2024-2025 | Glassia |
| Philips North America LLC | $145.35 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $142.83 | 2025 | Zerbaxa |
| Verona Pharma, INC. | $134.82 | 2025 | Ohtuvayre |
| Abbvie INC. | $128.79 | 2023 | |
| Viatris Specialty LLC | $128.37 | 2025 | Yupelri |
| Mylan Specialty L.P. | $111.50 | 2023-2024 | Yupelri |
| Lilly USA, LLC | $82.70 | 2021-2025 | Zepbound, Mounjaro |
| Intuitive Surgical, INC. | $46.33 | 2024 | |
| Genentech USA, INC. | $36.14 | 2024-2025 | Xolair |
| Esperion Therapeutics, INC. | $24.29 | 2021 | |
| Ani Pharmaceuticals, INC. | $18.02 | 2025 | Purified Cortrophin Gel |
| 3b Medical, INC. | $16.74 | 2025 | Luna |
| Inogen, INC. | $16.44 | 2023 | Inogen At Home Stationary Concentrator |
| Sandoz INC. | $16.18 | 2025 | Treprostinil |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wicker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.